Preclinical safety and efficacy of in situ REIC/Dkk-3 Gene therapy for prostate cancer

Acta Medica Okayama

Volumn 66, Issue 1, 2012, Pages 7-16

  Kawauchi, Keiichiro ^a   Watanabe, Masami ^a   Kaku, Haruki ^a   Huang, Peng ^a   Sasaki, Kasumi ^a   Ochiai, Masakiyo Sakaguchi ^a   Huh, Nam ho ^a   Nasu, Yasutomo ^a   Kumon, Hiromi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Dickkopf 3; Gene therapy; Preclinical study; Prostate cancer; Reic

Indexed keywords

DKK3 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADENOVIRUS; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; GENE THERAPY; GENETICS; HUMAN; MALE; MOUSE; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ADENOVIRIDAE; ANIMALS; CELL LINE, TUMOR; GENE THERAPY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROSTATIC NEOPLASMS;

ADENOVIRIDAE; MUS;

EID: 84858251182     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ and Thun MJ Cancer statistics, 2005. CA Cancer J Clin (2005) 55: 10-30.
2. Rittmaster RS, Thomas LN, Wright AS, Murray SK, Carlson K, Douglas RC, Yung J, Messieh M, Bell D and Lazier CB The util ity of tissue transglutaminase as a marker of apoptosis during treatment and progression of prostate cancer. J Urol (1999) 162: 2165-2169.
3. Sehgal I, Baley PA and Thompson TC Transforming growth factor beta1 stimulates contrasting responses in metastatic versus pri mary mouse prostate cancer-derived cell lines in vitro. Cancer Res (1996)56: 3359-3365.
4. Ferreira CG, Epping M, Kruyt FA and Giaccone G Apoptosis: target of cancer therapy. Clin Cancer Res (2002) 8: 2024-2034
5. Curran S and Murray GI: Matrix metalloproteinases in tumour invasion and metastasis. J Pathol (1999) 189: 300-308
6. Krupnik VE, Sharp JD, Jiang C, Robison K, Chickering TW, Amaravadi L, Brown DE, Guyot D, Mays G, Leiby K, Chang B, Duong T, Goodearl AD, Gearing DP, Sokol SY and McCarthy SA Functional and structural diversity of the human Dickkopf gene family. Gene (1999) 238: 301-313.
7. Mao B, Wu W, Davidson G, Marhold J, Li M, Mechler BM, Delius H, Hoppe D, Stannek P, Walter C, Glinka A and Niehrs C Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature (2002) 417: 664-647.
8. Abarzua F, Sakaguchi M, Takaishi M, Nasu Y, Kurose K, Ebara S, Miyazaki M, Namba M, Kumon H and Huh NH Adenovirus-mediated overexpression of REIC/Dkk-3 selectively Induces apop tosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. Cancer Res (2005) 65: 9617-9622.
9. Edamura K, Nasu Y, Takaishi M, Kobayashi T, Abarzua F, Sakaguchi M, Kashiwakura Y, Ebara S, Saika T, Watanabe M, Huh NH and Kumon H Adenovirus-mediated REIC/Dkk-3 gene transfer inhibits tumor growth and metastasis in an orthotopic pros tate cancer model. Cancer Gene Ther (2007) 14: 765-772.
10. Abarzua F, Sakaguchi M, Tanimoto R, Sonegawa H, Li DW, Edamura K, Kobayashi T, Watanabe M, Kashiwakura Y, Kaku H, Saika T, Nakamura K, Nasu Y, Kumon H and Huh NH Heat shock proteins play a crucial role in tumor-specific apoptosis by REIC/Dkk-3. Int J Mol Med (2007) 20: 37-43.
11. Kawasaki K, Watanabe M, Sakaguchi M, Ogasawara Y, Ochiai K, Nasu Y, Doihara H, Kashiwakura Y, Huh NH and Kumon H Date H. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer. Cancer Gene Ther (2009) 16: 65-72.
12. Kashiwakura Y, Ochiai K, Watanabe M, Abarzua F, Sakaguchi M, Takaoka M, Tanimoto R, Nasu Y, Huh NH and Kumon H Down-regulation of inhibition of differentiation-1 via activation of activat ing transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis. Cancer Res (2008) 68: 8333-8341.
13. Abarzua F, Kashiwakura Y, Takaoka M, Watanabe M, Ochiai K, Sakaguchi M, Iwawaki T, Tanimoto R, Nasu Y, Huh NH and Kumon H An N-terminal 78 amino acid truncation of REIC/Dkk-3 effectively induces apoptosis. Biochem Biophys Res Commun (2008)375: 614-618.
14. Watanabe M, Kashiwakura Y, Huang P, Ochiai K, Futami J, Li SA, Takaoka M, Nasu Y, Sakaguchi M, Huh NH and Kumon H Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression. Int J Oncol (2009) 34: 657-663.
15. Nasu Y, Saika T, Ebara S, Kusaka N, Kaku H, Abarzua F, Manabe D, Thompson TC and Kumon H Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapy. Mol Ther (2007) 15: 834-840.
16. Freytag SO, Khil M, Strieker H, Peabody J, Menon M, DePeralta-Venturina M, Nafziger D, Pegg J, Paielli D, Brown S, Barton K, Lu M, Aguilar-Cordova E and Kim JH Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer. Cancer Res (2002)62: 4968-4976.
17. Kubo H, Gardner TA, Wada Y, Koeneman KS, Gotoh A, Yang L, Kao C, Lim SD, Amin MB, Yang H, Black ME, Matsubara S, Nakagawa M, Gillenwater JY, Zhau HE and Chung LW Phase I dose escalation clinical trial of adenovirus vector carrying osteo-calcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer. Hum Gene Ther(2003)14: 227-241.
18. van der Linden RR, Haagmans BL, Mongiat-Artus P, van Doornum GJ, Kraaij R, Kadmon D, Aguilar-Cordova E, Osterhaus AD, van der Kwast TH and Bangma CH Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancer. Eur Urol (2005) 48: 153-161.
19. Tsuji T, Nozaki I, Miyazaki M, Sakaguchi M, Pu H, Hamazaki Y, Iijima O and Namba M Antiproliferative activity of REIC/Dkk-3 and its significant down-regulation in non-small-cell lung carcino mas. Biochem Biophys Res Commun (2001) 289: 257-263.
20. Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y and Namba M A REIC gene shows down-regulation in human immortalized cell and human tumor-derived cell lines. Biochem Biophys Res Commun (2000) 268: 20-24.
21. Hsieh SY, Hsieh PS, Chiu CT and Chen WY Dickkopf-3/REIC functions as a suppressor gene of tumor growth. Oncogene (2004) 23: 9183-9189.
22. Driesse MJ, Vincent AJ, Sillevis Smitt PA, Kros JM, Hoogerbrugge PM, Avezaat CJ, Valerio D and Bout A Intracerebral injection of adenovirus harboring the HSVtk gene combined with ganciclovir administration: toxicity study in nonhuman primates. Gene Ther (1998)5: 1122-1129.
23. Morral N, O'Neal WK, Rice K, Leland MM, Piedra PA, Aguilar-Córdova E, Carey KD, Beaudet AL and Langston C Lethal toxic ity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons. Hum Gene Ther (2002) 13: 143-154.
24. Su C, Cao H, Tan S, Huang Y, Jia X, Jiang L, Wang K, Chen Y, Long J, Liu X, Wu M, Wu X and Qian Q Toxicology profiles of a novel p53-armed replication-competent oncolytic adenovirus in rodents, felids, and nonhuman primates. Toxicol Sci (2008) 106: 242-250.
25. Muruve DA, Barnes MJ, Stillman IE and Libermann TA Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum Gene Ther (1999) 10: 965-976.
26. Teramoto S, Johnson LG, Huang W, Leigh MW and Boucher RC Effect of adenoviral vector infection on cell proliferation in cultured primary human airway epithelial cells. Hum Gene Ther (1995) 6: 1045-1053.